We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

64 hedge funds and large institutions have $274M invested in Arcus Biosciences in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 22

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

12% more funds holding

Funds holding: 57 → 64 (+7)

3.72% more ownership

Funds ownership: 46.66% → 50.38% (+3.7%)

6% less capital invested

Capital invested by funds: $293M → $274M (-$18.6M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
64
Holders Change
+7
Holders Change %
+12.28%
% of All Funds
1.47%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
29
Increased
13
Reduced
11
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$35.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.96M
3
HIM
Hillhouse Investment Management
Cayman Islands
+$5.37M
4
BlackRock
BlackRock
New York
+$4.95M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.01M

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management IV
California
-$5.57M
2
BI
BVF Inc
California
-$4.86M
3
Millennium Management
Millennium Management
New York
-$2.8M
4
PHS
PFM Health Sciences
California
-$2.59M
5
MWNA
Marshall Wace North America
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
26
Virtus ETF Advisers
New York
$609K +$780K +49,734 New
Charles Schwab
27
Charles Schwab
California
$491K +$628K +40,041 New
JC
28
JBF Capital
Colorado
$358K -$1.11M -70,751 -71%
TD Asset Management
29
TD Asset Management
Ontario, Canada
$358K – – –
Goldman Sachs
30
Goldman Sachs
New York
$353K -$1.57M -100,172 -78%
Millennium Management
31
Millennium Management
New York
$336K -$2.8M -178,518 -87%
LFM
32
Lumina Fund Management
New York
$208K +$227K +14,450 +567%
MML Investors Services
33
MML Investors Services
Massachusetts
$205K +$263K +16,740 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$196K +$252K +16,047 New
Morgan Stanley
35
Morgan Stanley
New York
$146K +$93.2K +5,940 +99%
HH
36
Hilltop Holdings
Texas
$136K +$174K +11,075 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$135K +$173K +11,000 New
Deutsche Bank
38
Deutsche Bank
Germany
$124K +$158K +10,081 New
CSS
39
Cubist Systematic Strategies
Connecticut
$123K +$17.5K +1,113 +13%
WMSA
40
Weiss Multi-Strategy Advisers
New York
$122K +$157K +10,000 New
Wells Fargo
41
Wells Fargo
California
$120K -$3.14K -200 -2%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$97K +$124K +7,908 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$77K +$98.9K +6,300 New
PIM
44
Partner Investment Management
California
$64K -$6.92K -441 -8%
Citigroup
45
Citigroup
New York
$47K +$12.8K +814 +27%
Barclays
46
Barclays
United Kingdom
$41K +$51.1K +3,255 New
AIG
47
American International Group
New York
$41K +$52.8K +3,366 New
TRCT
48
Tower Research Capital (TRC)
New York
$27K +$34.8K +2,216 New
CF
49
Centaurus Financial
California
$24K +$31.4K +2,000 New
SO
50
STRS Ohio
Ohio
$18K +$23.5K +1,500 New
1
2
3 4

RCUS Hedge Fund Activity: Q2 2018 in Review

64 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2018, worth a combined $274M — down 6.4% from $293M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RCUS positions and 22 closed out — a net gain of 7 holders — while 13 added to existing stakes and 11 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $35.8M. The largest seller was Foresite Capital Management IV, cutting an estimated $5.57M.

  • 64 institutional investors held Arcus Biosciences (RCUS) as of Q2 2018, up from 57 in Q1 2018.
  • Funds reported $274M of Arcus Biosciences stock for Q2 2018, down 6.4% quarter-over-quarter.
  • 29 funds opened new Arcus Biosciences positions in Q2 2018 and 22 closed out, a net change of +7 holders.
  • The largest Arcus Biosciences buyer in Q2 2018 was Wellington Management Group, an estimated $35.8M added.
  • The largest Arcus Biosciences seller in Q2 2018 was Foresite Capital Management IV, an estimated $5.57M sold.

Based on aggregated 13F filings for Q2 2018.